0000000000-24-014214.txt : 20250306 0000000000-24-014214.hdr.sgml : 20250306 20241223143610 ACCESSION NUMBER: 0000000000-24-014214 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20241223 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD SEC FILE NUMBER: 005-88023 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-24-199005 LETTER 1 filename1.pdf begin 644 filename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end TEXT-EXTRACT 2 filename2.txt December 23, 2024 Mark J. Foley President and Chief Executive Officer Revance Therapeutics, Inc. 1222 Demonbreun Street, Suite 2000 Nashville, TN 37203 Re: Revance Therapeutics, Inc. Schedule 14D9 filed December 12, 2024 File No. 005-88023 Dear Mark J. Foley: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. All defined terms used here have the same meaning as in your filing. Schedule 14D9 filed December 12, 2024 General 1. Refer to the following disclosures: At the top of page 4 that the summary and description of the Confidentiality Agreement "do not purport to be complete"; The first full paragraph on page 41 that the summary of the Centerview financial analysis "does not purport to be a complete description of the financial analyses performed or factors considered by, and underlying the opinion of, Centerview..." The third paragraph on page 53 stating that the "summary of appraisal rights under the DGCL is not complete... Please revise to remove the implication that these and any other summaries presented in your filing are not complete. While you may include appropriate disclaimers December 23, 2024 Page 2 concerning the nature of a summary generally, summaries must be complete in describing all material analyses or terms. You may direct investors to read exhibits or annexes for a more complete discussion. Background of the Offer and the Merger, page 12 2. We note multiple references in this section to "material open terms" in the merger agreement and other transactional documents being negotiated between Revance and Crown. With a view towards disclosure, please describe these material open terms. Certain Unaudited Prospective Financial Information of Revance, page 35 3. We note references to summaries of the April, August, and November Projections. Please revise to include the full projections instead of their summaries. Summary of Centerview Financial Analysis, page 41 4. For each of the valuation methodologies listed, provide the per share value or ranges of values yielded. We remind you that the filing persons are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please direct any questions to Brian Soares at 202-551-3690 or Christina Chalk at 202-551-3263. Sincerely, Division of Corporation Finance Office of Mergers & Acquisitions